Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder

F. W. Lohoff, J. L. Sorcher, A. D. Rosen, K. L. Mauro, R. R. Fanelli, R. Momenan, C. A. Hodgkinson, L. F. Vendruscolo, G. F. Koob, M. Schwandt, D. T. George, I. S. Jones, A. Holmes, Z. Zhou, M. J. Xu, B. Gao, H. Sun, M. J. Phillips, C. Muench, Zachary A Kaminsky

Research output: Contribution to journalArticle

Abstract

Alcohol use disorder (AUD) is a common and chronic disorder with substantial effects on personal and public health. The underlying pathophysiology is poorly understood but strong evidence suggests significant roles of both genetic and epigenetic components. Given that alcohol affects many organ systems, we performed a cross-tissue and cross-phenotypic analysis of genome-wide methylomic variation in AUD using samples from 3 discovery, 4 replication, and 2 translational cohorts. We identified a differentially methylated region in the promoter of the proprotein convertase subtilisin/kexin 9 (PCSK9) gene that was associated with disease phenotypes. Biological validation showed that PCSK9 promoter methylation is conserved across tissues and positively correlated with expression. Replication in AUD datasets confirmed PCSK9 hypomethylation and a translational mouse model of AUD showed that alcohol exposure leads to PCSK9 downregulation. PCSK9 is primarily expressed in the liver and regulates low-density lipoprotein cholesterol (LDL-C). Our finding of alcohol-induced epigenetic regulation of PCSK9 represents one of the underlying mechanisms between the well-known effects of alcohol on lipid metabolism and cardiovascular risk, with light alcohol use generally being protective while chronic heavy use has detrimental health outcomes.

Original languageEnglish (US)
JournalMolecular Psychiatry
Volume23
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Proprotein Convertases
Subtilisin
Alcohols
Epigenomics
Lipid Metabolism
Genetic Promoter Regions
LDL Cholesterol
Methylation
Down-Regulation
Public Health
Genome
Phenotype
Light

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder. / Lohoff, F. W.; Sorcher, J. L.; Rosen, A. D.; Mauro, K. L.; Fanelli, R. R.; Momenan, R.; Hodgkinson, C. A.; Vendruscolo, L. F.; Koob, G. F.; Schwandt, M.; George, D. T.; Jones, I. S.; Holmes, A.; Zhou, Z.; Xu, M. J.; Gao, B.; Sun, H.; Phillips, M. J.; Muench, C.; Kaminsky, Zachary A.

In: Molecular Psychiatry, Vol. 23, No. 9, 01.09.2018.

Research output: Contribution to journalArticle

Lohoff, FW, Sorcher, JL, Rosen, AD, Mauro, KL, Fanelli, RR, Momenan, R, Hodgkinson, CA, Vendruscolo, LF, Koob, GF, Schwandt, M, George, DT, Jones, IS, Holmes, A, Zhou, Z, Xu, MJ, Gao, B, Sun, H, Phillips, MJ, Muench, C & Kaminsky, ZA 2018, 'Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder', Molecular Psychiatry, vol. 23, no. 9. https://doi.org/10.1038/mp.2017.168
Lohoff, F. W. ; Sorcher, J. L. ; Rosen, A. D. ; Mauro, K. L. ; Fanelli, R. R. ; Momenan, R. ; Hodgkinson, C. A. ; Vendruscolo, L. F. ; Koob, G. F. ; Schwandt, M. ; George, D. T. ; Jones, I. S. ; Holmes, A. ; Zhou, Z. ; Xu, M. J. ; Gao, B. ; Sun, H. ; Phillips, M. J. ; Muench, C. ; Kaminsky, Zachary A. / Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder. In: Molecular Psychiatry. 2018 ; Vol. 23, No. 9.
@article{06e15e9700084c7dad8c72c0c6f2dd55,
title = "Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder",
abstract = "Alcohol use disorder (AUD) is a common and chronic disorder with substantial effects on personal and public health. The underlying pathophysiology is poorly understood but strong evidence suggests significant roles of both genetic and epigenetic components. Given that alcohol affects many organ systems, we performed a cross-tissue and cross-phenotypic analysis of genome-wide methylomic variation in AUD using samples from 3 discovery, 4 replication, and 2 translational cohorts. We identified a differentially methylated region in the promoter of the proprotein convertase subtilisin/kexin 9 (PCSK9) gene that was associated with disease phenotypes. Biological validation showed that PCSK9 promoter methylation is conserved across tissues and positively correlated with expression. Replication in AUD datasets confirmed PCSK9 hypomethylation and a translational mouse model of AUD showed that alcohol exposure leads to PCSK9 downregulation. PCSK9 is primarily expressed in the liver and regulates low-density lipoprotein cholesterol (LDL-C). Our finding of alcohol-induced epigenetic regulation of PCSK9 represents one of the underlying mechanisms between the well-known effects of alcohol on lipid metabolism and cardiovascular risk, with light alcohol use generally being protective while chronic heavy use has detrimental health outcomes.",
author = "Lohoff, {F. W.} and Sorcher, {J. L.} and Rosen, {A. D.} and Mauro, {K. L.} and Fanelli, {R. R.} and R. Momenan and Hodgkinson, {C. A.} and Vendruscolo, {L. F.} and Koob, {G. F.} and M. Schwandt and George, {D. T.} and Jones, {I. S.} and A. Holmes and Z. Zhou and Xu, {M. J.} and B. Gao and H. Sun and Phillips, {M. J.} and C. Muench and Kaminsky, {Zachary A}",
year = "2018",
month = "9",
day = "1",
doi = "10.1038/mp.2017.168",
language = "English (US)",
volume = "23",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder

AU - Lohoff, F. W.

AU - Sorcher, J. L.

AU - Rosen, A. D.

AU - Mauro, K. L.

AU - Fanelli, R. R.

AU - Momenan, R.

AU - Hodgkinson, C. A.

AU - Vendruscolo, L. F.

AU - Koob, G. F.

AU - Schwandt, M.

AU - George, D. T.

AU - Jones, I. S.

AU - Holmes, A.

AU - Zhou, Z.

AU - Xu, M. J.

AU - Gao, B.

AU - Sun, H.

AU - Phillips, M. J.

AU - Muench, C.

AU - Kaminsky, Zachary A

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Alcohol use disorder (AUD) is a common and chronic disorder with substantial effects on personal and public health. The underlying pathophysiology is poorly understood but strong evidence suggests significant roles of both genetic and epigenetic components. Given that alcohol affects many organ systems, we performed a cross-tissue and cross-phenotypic analysis of genome-wide methylomic variation in AUD using samples from 3 discovery, 4 replication, and 2 translational cohorts. We identified a differentially methylated region in the promoter of the proprotein convertase subtilisin/kexin 9 (PCSK9) gene that was associated with disease phenotypes. Biological validation showed that PCSK9 promoter methylation is conserved across tissues and positively correlated with expression. Replication in AUD datasets confirmed PCSK9 hypomethylation and a translational mouse model of AUD showed that alcohol exposure leads to PCSK9 downregulation. PCSK9 is primarily expressed in the liver and regulates low-density lipoprotein cholesterol (LDL-C). Our finding of alcohol-induced epigenetic regulation of PCSK9 represents one of the underlying mechanisms between the well-known effects of alcohol on lipid metabolism and cardiovascular risk, with light alcohol use generally being protective while chronic heavy use has detrimental health outcomes.

AB - Alcohol use disorder (AUD) is a common and chronic disorder with substantial effects on personal and public health. The underlying pathophysiology is poorly understood but strong evidence suggests significant roles of both genetic and epigenetic components. Given that alcohol affects many organ systems, we performed a cross-tissue and cross-phenotypic analysis of genome-wide methylomic variation in AUD using samples from 3 discovery, 4 replication, and 2 translational cohorts. We identified a differentially methylated region in the promoter of the proprotein convertase subtilisin/kexin 9 (PCSK9) gene that was associated with disease phenotypes. Biological validation showed that PCSK9 promoter methylation is conserved across tissues and positively correlated with expression. Replication in AUD datasets confirmed PCSK9 hypomethylation and a translational mouse model of AUD showed that alcohol exposure leads to PCSK9 downregulation. PCSK9 is primarily expressed in the liver and regulates low-density lipoprotein cholesterol (LDL-C). Our finding of alcohol-induced epigenetic regulation of PCSK9 represents one of the underlying mechanisms between the well-known effects of alcohol on lipid metabolism and cardiovascular risk, with light alcohol use generally being protective while chronic heavy use has detrimental health outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85056460836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056460836&partnerID=8YFLogxK

U2 - 10.1038/mp.2017.168

DO - 10.1038/mp.2017.168

M3 - Article

C2 - 28848234

AN - SCOPUS:85056460836

VL - 23

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 9

ER -